Glow forward. On your own terms.

Skin collagen falls by around 30% in the first five years after menopause, then continues at roughly 2% a year — which is why skin thins and loses elasticity fastest in the early postmenopausal window.

The original measurements are Brincat's 1980s skin-thickness studies; this review is the readable summary with the numbers intact.

Daily broad-spectrum sunscreen use slows visible skin aging: in a 4.5-year randomised community trial, the daily-sunscreen group showed no detectable increase in skin aging compared with the discretionary-use group.

This is the study behind 'SPF before serum'. It beats every anti-aging active ever tested, and it is free-ish.

Topical retinoids (tretinoin and relatives) have the strongest trial evidence of any topical for fine lines, roughness and pigmentation.

Also the honest source on the irritation and the slow ramp-up.

Bakuchiol performed comparably to retinol for wrinkle surface area and pigmentation over 12 weeks, with significantly less scaling and stinging.

One small double-blind trial, n=44. Real, but modest — treat it as the tolerable alternative, not the upgrade.

Visible light drives melasma, so tinted (iron-oxide) sunscreens outperform untinted mineral SPF for hormonal pigmentation.

Why the tinted version is not a cosmetic preference if you have melasma.

Topical minoxidil is the best-supported treatment for female pattern hair loss, with consistent increases in hair count versus placebo across trials.

Also covers antiandrogens and laser devices, and is candid about how weak most of that evidence is by comparison.

Low-dose oral minoxidil is increasingly used off-label for hair loss when topical is poorly tolerated, with growth benefit and a manageable side-effect profile in reported series.

Case-series level evidence, not trials. Worth asking about; not something to start without a prescriber.

Fat mass accelerates and lean mass declines during the menopause transition on a timeline tied to the final menstrual period, independent of chronological aging.

SWAN followed body composition through the transition. The change is hormonal timing, not willpower.

There is robust scientific evidence that endocrine-disrupting chemicals — including phthalates and other compounds found in personal-care products — interfere with hormone action at everyday exposure levels.

The reason we say 'informed, not anxious': the science is real, the individual-product risk is usually small.

Red and near-infrared light treatment improved skin complexion, collagen density and wrinkle measures versus untreated controls in a controlled trial of 136 volunteers.

Devices used were clinical-grade. This does not validate a $40 mask, and the effect is a nudge, not a lift.

A 20-week structured facial-exercise programme produced a modest improvement in rated upper- and lower-cheek fullness in 27 midlife women.

Single small trial, no control group, raters were blinded. This is the entire 'face yoga works' evidence base.

Low-dose vaginal estrogen raises systemic estradiol minimally and is the recommended treatment for genitourinary syndrome of menopause, including for many women with a history of breast cancer after discussion with their oncology team.

The document to hand over if you are told vaginal estrogen is off-limits by default.